Clinical Trial Update: Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults [Phase 1]

View source ↗

Summary

Phase 1 update reporting safety and immunogenicity data for a candidate tuberculosis vaccine tested in PPD-negative adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Candidate tuberculosis vaccine (undisclosed name)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis (TB) | Phase 1 | Status: COMPLETED